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Abstract Melanin is major factor that determines skin
color as well as one of the defense systems that prevent the
UV-induced damage. In case of abnormal concentration of
melanin, skin diseases or problems occur such as albinism,
leukoplakia, melasma, freckles, moles, and lentigo. With
the lifespan of humans has been extended, importance of
‘life quality’ has been increased. White and clean skin is
very important part of the satisfaction of appearance,
especially for Asia women. The aim of this study was to
find an anti-melanogenesis activity for which the aerial part
of Pueraria thunbergiana can be utilized based on the
increase in demands for cosmetics, particularly natural
products. We demonstrated anti-pigmentation effects of
aerial part of P. thunbergiana by measuring melanin con-
tent and through staining in the B16F10 melanoma cell
line. The aerial part of P. thunbergiana decreased tyrosi-
nase activity significantly in B16F10 cell cultures, while
there is no direct effect on enzyme in cell-free conditions.
To define the mechanisms, real-time PCR, western blot,
glucosidase activity and antioxidant activity assay were
implemented. As results, we demonstrated that aerial part
of P. thunbergiana has anti-melanogenesis activity via two
mechanisms. One is downgrading microphthalmia-asso-
ciated transcription factor by activating Akt/GSK-3b.
Consequently, transcription of tyrosinase and tyrosinase-
related protein 1 is decreased. Another is interrupting
maturation of tyrosinase through inhibiting a-glucosidase.
Furthermore, aerial part of P. thunbergiana showed great
efficacy on pigmentation in vivo. These results suggest that
aerial part of P. thunbergiana can be used as an anti-
melanogenic agent.
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Introduction
Pueraria thunbergiana, also known as the kudzu, is a
species of climbing plant belonging to the Leguminosae
family. The root and flower of P. thunbergiana, used in
traditional medicine, have various medicinal properties
[15, 33, 35, 36, 38]. However, the vine of P. thunbergiana
is commonly discarded as a waste product and presents an
environmental problem. The vine grows by climbing
adjoining structures and trees, and destroys forests and
landscape because of its weight and fast rate of growth. In
some countries, P. thunbergiana is considered among the
invasive species and seen as a threat to the ecosystem, with
its management exacting a high cost, both financially and
in terms of manpower [9, 16].
Melanin is a major factor that determines skin color, as
well as one of the defense systems that prevent UV-
induced skin damage. Abnormal concentrations of melanin
manifest as skin diseases or problems, such as albinism,
leukoplakia, melasma, freckles, moles, and lentigo. Skin-
whitening agents are commonly applied for treating
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pigmentation and pigmentary diseases. Because of an
increasing interest in herbs, many studies focused on dis-
covering novel natural skin-whitening agents that are cur-
rently underway [30]. We investigated, therefore, whether
the aerial part of P. thunbergiana, which is currently
considered a waste product, has potentially useful skin-
whitening effects.
Melanin is synthesized in melanocytes by enzyme-
related mechanism, such as tyrosinase, tyrosinase-related
protein 1 (TRP1) and tyrosinase-related protein 2 (TRP2).
The first step of melanogenesis is a transformation of L-
tyrosine into 3,4-dihydroxyphenylalanine (L-DOPA), and
this L-DOPA is converted into DOPA quinine [28]. Then
from this product, melanin is synthesized by subsequent
transformation. First two ensuing stages, regulated by
tyrosinase, are rate-limiting steps because the rest of the
melanin synthesis process can go along naturally at a
physiological pH [11]. Since tyrosinase is the key enzyme
of melanogenesis, many whitening agents are targeting the
tyrosinase by various mechanisms such as interference with
tyrosinase catalytic activity directly, inhibition of mRNA
expression, interruption of tyrosinase maturation, and
acceleration of tyrosinase degradation [1].
Transcription levels of melanogenic genes are regulated
by microphthalmia-associated transcription factor (MITF)
[32]. MITF is expressed by that kind of stimulating factors.
On the other hand, mitogen-activated protein kinase
(MEK)/extracellular signal-regulated kinases (ERK) and
Akt/glycogen synthase kinase-3b (GSK-3b) signals path-
ways are involved in the down-regulation of melanogenesis
by phosphorylating MITF [18, 34]. The phosphorylated
MITF decreases its activity, binding to tyrosinase promoter
site, and eventually degrades. Thereby, activation of MEK/
ERK or Akt/GSK-3 inhibits melanin synthesis [14, 18].
The melanogenesis is regulated by nutritional and hor-
monal factors. L-tyrosine and L-DOPA are not only sub-
strates but also bioregulator for melanogenesis. Regulation
for melanocyte function of L-tyrosinase and L-DOPA can
be mediated through specific receptors or without receptors
[28]. In addition, there are complex multiple hormonal
stimulators such as MSH, adrenocorticotropic hormone
(ACTH), endorphin and stem cell factor (SCF) and inhib-
itors such as serotonin, melatonin, dopamine, acetylcholine
and melanin-concentrating hormone (MCH) [25].
Since in vivo study is also important regarding the
transmembrane or transdermal permeation, it was under-
taken using cream formulations. There are differences
between epidermal and follicular melanogenesis although
basic features such as existence of melanocyte and mela-
nosome are common. The follicular melanogenesis
depends on anagen stage of hair cycle, whereas epidermal
melanogenesis is continuous and follicular melanocyte is
more influenced by aging [26]. Consequently, melanin-
generating hairless mice irradiated UVB were used for
in vivo study [31]. When skin exposes to UV, a-melano-
cyte-stimulating hormone (a-MSH), one of the important




Antibiotic–antimycotic, bovine serum albumin (BSA),
Dulbecco’s modified Eagle’s medium (DMEM), and fetal
bovine serum were purchased from Life Technologies
(Carlsbad, CA, USA). Acarbose, dimethyl sulfoxide
(DMSO), 3,4-dihydroxy-L-phenylalanine (L-DOPA), 2,2-
diphenyl-1-picrylhydrazyl (DPPH), ethylenediaminete-
traacetic acid (EDTA), a-glucosidase (EC 3.2.1.20, from
baker’s yeast, 77 U/mg), LY294002, a-melanocyte-stimu-
lating hormone (a-MSH), mushroom tyrosinase and q-
Nitrophenyl-a-D-glucopyranoside were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Fontana–Masson
staining kit was obtained from IHCWORLD (Woodstock,
MD, USA). Phosphate-buffered saline (PBS) was obtained
from Bioworld Technology, Inc. (BioWorld, USA). easy-
BlueTM Total RNA extraction kit was purchased from
Intron Biotechnology, Inc. (iNtRON Biotechnology,
Seongnam, Korea). TaqMan RNA-to-CtTM 1-Step Kits
were purchased from Applied Biosystems (USA). RIPA
buffer was obtained from Biosesang Inc. (Seongnam,
Korea). Protease inhibitor cocktail tablets were purchased
from Roche Diagnostics (Switzerland). Antibodies were
purchased from Cell Signaling Technology (Danvers, MA,
USA) and Santa Cruz Biotechnology Inc. (Santa Cruz, CA,
USA). ECL reagent was purchased from GE Healthcare.
Extraction of plant material
Aerial parts of P. thunbergiana were collected from Jinan,
Jeonbuk, Korea, in November 2010, and extracted by the
Hanpoong Pharm and Foods Company (Hanpoong Pharm.
CO., Ltd.). Briefly, dried and pulverized materials (2 kg)
were boiled with 2 L of distilled water and a range of
ethanol concentrations (0, 30, 70, and 95 %) for 3 h. The
solvent was then removed under reduced pressure in a
rotary evaporator (N-1000S, EYELA, Japan) to yield a
water extract (439.5 g), 30 % ethanolic extract (409.2 g),
70 % ethanolic extract (436.7 g), and a 95 % ethanolic
extract (284.8 g).
The respective extracts were suspended with distilled
water, and then partitioned with ethyl acetate (EtOAc). The
EtOAc and aqueous fractions were independently evapo-
rated under reduced pressure at 60 C, and the extracts
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completely dried. Aqueous fractions, with increasing eth-
anol concentration in the initial extraction step, are referred
to as extract Nos. 1–4, while the organic (EtOAc) fraction
extracts are referred to as Nos. 5–8 (Fig. 1).
High-performance liquid chromatography analysis
The isoflavone content of the extracts was quantitated by
high-performance liquid chromatography (HPLC; Waters
2695 system, Waters Co., Milford, MA, USA) using a
CAPCELLPAK UG 120 250 9 4.6 mm, 5-lm column
(Shiseido Co., Tokyo, Japan). Separation and quantification
of isoflavones were achieved at 30 C using a solvent
gradient from solution A, a 10 % aqueous methanol solu-
tion with 2 % acetic acid, to solution B, a 98 % aqueous
methanol solution with 2 % acetic acid, at a flow rate of
1 mL/min. Peaks were detected by measuring absorbance
at 260 nm. The presence of isoflavones was confirmed by
comparing the observed peaks with the retention time of
the corresponding standards (Wako Chemical Co., Osaka,
Japan). The chromatogram of total isoflavones is shown in
Fig. 2, and the chemical structures of each isoflavone are
indicated in Fig. 3. The isoflavone aglycone, and glycoside
concentrations in each extract are listed in Table 1.
Cell culture and treatment with extracts
Murine B16F10 melanoma cells purchased from ATCC
(Manassas, VA, USA) were cultured in DMEM with 10 %
(v/v) fetal bovine serum and 1 % (v/v) antibiotic–antimy-
cotic. The cells were incubated in a humidified incubator
under 5 % CO2 at 37 C. Aqueous fractions are dissolved
in DDW and EtOAc fractions are dissolved in DMSO.
Controls of B16F10 cells were added DDW or DMSO at
the same concentration as in the treated cells.
Cell viability assay
Cell proliferation was evaluated by performing the MTT
assay. The cells (3 9 103 cells/well) were seeded into a
96-well plate and incubated for 24 h; the cells were sub-
sequently exposed to the P. thunbergiana extracts at a
range of concentrations (0, 5, 10, 50, 100, 500, and
1,000 lg/mL) for 2 days. Thereafter, serum-free MTT
medium was added to each well to the final concentration
of 1 mg/mL, and incubation performed for 2–4 h at 37 C.
The MTT medium was removed from the wells, and
DMSO was added; thereafter, the plate was placed on a
shaker for 5 min. Absorbance was read at 540 nm using a
microplate spectrophotometer (SpectraMax 190, USA).
Melanin content
The B16F10 cells (3 9 104 cells/well) were seeded in a
6-well plate and exposed to a-MSH (100 nM) for 1 day.
The treatment was performed with a combination of a-
MSH (100 nM) and P. thunbergiana extracts for 2 days.
The cells were harvested by trypsinization and washed
twice with PBS and alcohol. 2 9 105 cells were dissolved
in 200 lL of 1 N NaOH with 10 % DMSO at 90 C for
1 h. The resulting melanin concentration was quantified by
measuring the absorbance at 475 nm.
Fig. 1 Extraction and partition of fractions from aerial part of P. thunbergiana
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Fig. 2 HPLC chromatogram
showing peaks corresponding to
isoflavones in extracts of the
aerial part of P. thunbergiana,
with absorbance evaluated at
260 nm
Fig. 3 Chemical structure of
isoflavones in extracts of the
aerial part of P. thunbergiana
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Mushroom tyrosinase activity
Reactions were performed in potassium phosphate buffer
(pH 6.81). Mushroom tyrosinase solution was prepared by
dissolving 25,000 units in 6 mL of 0.1 mM potassium
phosphate buffer and adding 2 mL of distilled water. L-
DOPA solution (0.01 %) in distilled water was used as the
enzyme substrate. A mixture of 160 lL of buffer, 20 lL of
substrate, 10 lL of P. thunbergiana extract, and 10 lL of
enzyme was added to a 96-well plate. Tyrosinase activity
was quantified by measuring absorbance at 475 nm after
2 min. Kojic acid was used as a positive control. The data
are expressed as mean ± SD.




Another method of measuring tyrosinase activity was repe-
ated since there are complex regulations of tyrosinase acti-
vation [24]. The B16F10 cells were exposed to a-MSH
(100 nM) for 1 day and treated with a combination of extracts
and a-MSH for 2 days. The pellet was obtained by trypsin-
ization and washed with PBS. The cells were lysed with 0.1 M
sodium phosphate buffer (pH 6.8) containing 5 mM EDTA,
1 % Triton X-100, and 0.1 % phenylmethylsulfonyl fluoride
(PMSF) in ice for 30 min. After centrifugation of the lysate at
15,000 rpm for 30 min at 4 C, cellular tyrosinase activity
was measured in the resulting supernatant. Enzyme activity
was normalized to protein concentration, as determined by
Bradford assay. The cellular tyrosinase and 0.1 % L-DOPA
reaction were performed in 0.1 M sodium phosphate buffer at
37 C for 1 h. Tyrosinase activity was quantified by measur-
ing the absorbance at 475 nm.
Real-time PCR
Quantification of selected genes transcript by real-time
PCR was performed using a TaqMan RNA-to-CtTM
1-Step Kit according to the manufacturer’s instructions.
The mRNA was extracted with easy-BlueTM Total RNA
extraction kit and quantified by Nano Drop. Relative ratio
of a target gene expression was calculated with the DCt
method.
Western blot analysis
After treatment with a range of concentrations (0, 10, 50,
and 100 lg/mL) of extracts, the B16F10 cells were washed
with PBS, and lysed by RIPA buffer in ice to get the
protein. Next, 20–50 lg of proteins was subjected to
electrophoresis on 10–15 % sodium dodecyl sulfate-poly-
acrylamide gels (SDS-PAGE). Following electrophoresis,
the proteins were transferred to nitrocellulose membranes,
and the membranes were blocked with 5 % skimmed milk
or 5 % BSA in PBS with 0.1 % Tween 20 (PBST). Then,
the proteins were probed using antibodies. The immuno-
blots were developed and visualized using an enhanced
chemiluminescence (ECL) detection system (Amersham
Biosciences, Piscataway, NJ, USA). The western blot was
imaged using the Chemi Documentation Imaging Sys-
tem and quantified using densitometric program (Image J).
GAPDH and b-actin were used as an internal control.
Glucosidase activity assay
Inhibition activities of a-glucosidase were evaluated
according to the chromogenic method described by McCue
et al. [17]. Yeast a-glucosidase (0.5 unit/mL) 20 lL, 0.1 M
phosphate buffer (pH 6.9) 120 and 10 lL of test sample
dissolved in DMSO at various concentrations were mixed
in a microplate well. After incubating for 15 min at 37 C,
20 lL of q-Nitrophenyl-a-D-glucopyranoside (5 mM) was
added to substrates and incubated for an additional 15 min.
The reaction was terminated by 80 lL of 0.2 M sodium
carbonate (Na2CO3) solution. The absorbance was mea-
sured at 405 nm. Acarbose was used as positive control.
Table 1 Composition of




Aglycone (mg/g) Glycoside (mg/g)
Daidzein Glycitein Genistein Daidzin Glycitin Genistin
Raw material 1.76 0.03 0.12 6.51 0.41 0.47
No. 1 6.27 0.27 0.29 45.74 3.45 3.33
No. 2 9.22 0.39 0.60 55.04 3.83 4.33
No. 3 10.14 0.33 0.71 53.12 3.90 4.26
No. 4 14.97 0.56 1.00 61.38 4.52 4.50
No. 5 114.69 3.94 5.76 125.64 14.80 349.91
No. 6 149.59 4.52 10.33 98.24 12.44 286.61
No. 7 93.61 2.77 6.82 61.83 8.13 162.36
No. 8 78.15 2.52 5.09 37.84 5.28 101.16
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Each experiment was conducted in triplicate, and the IC50
values of samples were calculated.
Antioxidant activity
DPPH was dissolved in methanol to a 0.1 mM concentration,
and mixed with the diluted P. thunbergiana extracts (0, 10,
50, and 100 lg/mL) in a 96-well plate in a 1:1 ratio. Reaction
was allowed to proceed in the dark for 30 min, and the
absorbance was measured at 520 nm. Ascorbic acid was
used as a standard. The data are expressed as mean ± SD.
Animals
Six-week-old male hairless mice, Hos: HRM2, were pur-
chased from Hoshino Laboratory Animals Inc. (Yashio,
Saitama, Japan). The animals were housed in a SPF animal
facility room at 23 ± 1 C and 50 ± 10 % relative humidity
with 12-h light/dark cycle with free access to standard
commercial diet and water. Creams containing 1 or 3 % of
No.6 extracts were used for assessing in vivo anti-melano-
genesis efficacy. There are five groups of mice in the animal
model; control group (applied cream base, CON), UVB-
exposed control group (UVB ? applied cream base, UVB),
positive control group (UVB ? applied 1 % kojic acid
cream, kojic acid), experiment group 1 [UVB ? applied
1 % No.6 cream, No.6 (1 %)] and experiment group 2
[UVB ? applied 3 % No.6 cream, No.6 (3 %)].
In vivo skin pigmentation determinations
The treatments were performed once per every day since
3 days before UVB irradiation by topically applying
100 mg of each cream on the dorsal skin of the animal. The
mice were anesthetized with a ketamine–xylazine mixture
(2 mL/kg, i.p., respectively) and after 30 min to absorb the
cream, exposed to UVB at 100, 150 and 200 mJ/cm2 once
per day for each 5 days, respectively. Colors of skin were
determined using a DSM II ColorMeter (Cortes Technol-
ogy). The results were expressed as L* values (value of 0
indicates black, 100 indicates white). At the 19 day, mice
were sacrificed and the dorsal skins were obtained. The
specimens were used for Fontana–Masson staining. DL*
were calculated as follows:
DL ¼ day 2 þ day 3 þ day 4
3
 




The B16F10 melanoma cells were cultured and treated in a
chamber slide. After removal of the medium, the cells were
fixed with 4 % formalin for 20 min and washed twice by
PBS containing 0.1 % Triton X-100. The cells were stained
with the Fontana–Masson staining kit according to manu-
facturer’s instructions.
Each specimen was soaked in formaldehyde to fix.
Then, paraffin processing and embedding were carried out.
The tissue blocks were sectioned at 4 lm. The skins were
stained with Fontana–Masson staining kit.
Briefly, the B16F10 cells or specimens were incubated
in pre-warmed FM silver nitrate solution, toned in gold
chloride solution, and soaked in 5 % sodium thiosulfate
solution. Finally, counterstaining was performed with the
Nuclear Fast Red Solution.
Statistical analysis
All results obtained from at least three independent
experiments were combined and analyzed using the Stu-
dent’s t test. All values were expressed as the mean ± SD.
The acceptable level of significance was established at
p values \0.05
Results
The aerial part of P. thunbergiana hinders
melanogenesis in B16F10 cells
To evaluate the whitening effect of the aerial part of P.
thunbergiana, B16F10 melanoma cells were treated with
the extracts at a range of concentrations that showed no
adverse effects on cell viability (Fig. 4). Melanin syn-
thesis was induced by a-MSH in B16F10 cells and
100 lg/mL, the highest concentration without cytotoxic-
ity, of samples were treated for screening. a-MSH is one
of the factors that stimulate pigmentation in mammals
[12]. The aqueous fractions of P. thunbergiana extracts
had no effects on melanogenesis, but the EtOAc-soluble
fractions of the extracts inhibited a-MSH-induced mela-
nin synthesis more effectively than did kojic acid, a
whitening agent used as a positive control (Fig. 5). When
the data are expressed as a percentage normalized to the
non-treated cells, the cells treated with extracts No.6
(EtOAc-soluble fraction of the 30 % EtOH extract), and
No.7 (EtOAc-soluble fraction of the 30 % EtOH extract)
showed 21.17 and 48.20 % of melanin contents,
respectively, lower than that shown by the non-treated
cells.
Further examination showed that the treatment of the
cells with the EtOAc-soluble fraction of P. thunbergiana
extracts reduced melanogenesis in a dose-dependent man-
ner (Fig. 6). The melanogenesis-suppressing activity of
extract Nos. 6 and 7, most significant samples in collective
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assessment, was confirmed visually by Fontana–Masson
staining (Fig. 7). Accumulation of melanin was observed in
a-MSH-treated B16F10 cells and treatment with P. thun-
bergiana extracts down-regulated the pigmentation in the
cells. At the highest concentration used, extract No.6
inhibited melanogenesis to the baseline (non-treated cells)
level.
The aerial part of P. thunbergiana indirectly inhibits
tyrosinase activity
The process of melanogenesis is regulated by an intracel-
lular enzymatic cascade. To determine if the aerial part of
P. thunbergiana directly affects tyrosinase, the key enzyme
for melanin synthesis, we used mushroom and cellular
tyrosinase activity assays. Unlike kojic acid, P. thun-
bergiana extracts did not exhibit any inhibitory effect on
the tyrosinase activity in cell-free condition (Fig. 8).
Interestingly, the cellular tyrosinase in B16F10 cells
stimulated by a-MSH was significantly inhibited by
treatment with P. thunbergiana extracts in a dose-depen-
dent manner (Fig. 9). In the case of extract No.6, cellular
tyrosinase activity declined to levels lower than those in the
non-treated cells (Fig. 9a).
Effects on expression of mRNA and protein
of tyrosinase
We conducted real-time PCR assay for inquiry about
effects of aerial part of P. thunbergiana on mRNA of
tyrosinase (Fig. 10a). Transcriptions of tyrosinase were
significantly attenuated compared to transcription of a-
MSH-stimulated cells. Moreover, we found dose-depen-
dent manner effects of Nos. 6 and 7. Especially, tyrosinase
expressions of B16F10 cells treated with 100 lg/mL were
lower than the level of non-treated cells. The decrease of
tyrosinase activity was further confirmed by western blot
assay (Fig. 10b). There were double bands, and these bands
indicate degrees of maturation of tyrosinase. Upper bands
for glycosylated tyrosinase represent the mature form,
Fig. 4 Concentration-dependent effects of aerial part of P. thun-
bergiana on B16F10 cell viability. Cytotoxicity of P. thunbergiana
extracts in B16F10 melanoma cells was evaluated by treating the cells
treated with aqueous or EtOAc fraction of extracts for 48 h. Cell
viability was determined using the MTT assays, and results are
expressed as percent viability relative to untreated cells
Fig. 5 Effect of aerial part of
P. thunbergiana on
melanogenesis in B16F10 cells.
B16F10 cells were cultured, and
following adherence, the cells
were treated with a-MSH. After
1 day, the cells were incubated
with combinations of
a-MSH and kojic acid or
P. thunbergiana extract Nos.
1–8. Melanogenesis was
quantified 2 days later, and the
results expressed relative to
controls. **p \ 0.01, and
***p \ 0.001 compared to cells
stimulated with a-MSH alone
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Fig. 6 Effect of EtOAc fractions on melanogenesis in B16F10 cells.
B16F10 cells were cultured, and following adherence, the cells were
treated with a-MSH. The cells were treated with a combination of a-
MSH with kojic acid, arbutin, or a range of concentrations of extract
Nos. 5–8 (5, 10, 50, and 100 lg/mL). The results were expressed
relative to untreated cells. *p \ 0.05, **p \ 0.01, and ***p \ 0.001
compared to a-MSH-stimulated cells
Fig. 7 Optical images (magnification 9400) showing melanin con-
tent with Fontana–Masson staining in B16F10 cells. After 24 h of a-
MSH pre-incubation, B16F10 cells were treated with a combination
of a-MSH and extract No. 6 or 7, arbutin, or kojic acid for 48 h.
Pigmentation observed upon Fontana–Masson staining (magnification
9400)
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while other bands for unglycosylated tyrosinase represent
the immature form. Tyrosinase becomes the active form
after being glycosylated. Treatment of Nos. 6 and 7
inhibited glycosylation of tyrosinase.
Inhibitory effects on a-glucosidase
To identify how aerial part of P. thunbergiana hinders
maturation of tyrosinase, the study about a-glucosidase
activity was conducted. Briefly, we demonstrated that
both Nos. 6 and 7 have a-glucosidase inhibitory activity.
The extracts inhibited a-glucosidase more effectively
than acarbose, the synthetic inhibitor of a-glucosidase
(Fig. 11). Dose–response curves of activity were
obtained, and the IC50 values were calculated. No. 6
dramatically reduced a-glucosidase activity with IC50 of
349.70 lg/mL. The IC50 of No. 7 was the smallest with
213.93 lg/mL which is about ten times lower than
acarbose with 2,010.34 lg/mL.
Effects on expression of mRNA and protein of TRP1
To find out effects of aerial part of P. thunbergiana on
TRP1, we examined the mRNA and protein levels after
treating a range of concentration of Nos. 6 and 7 (0, 10, 50,
and 100 lg/mL) on a-MSH-stimulated B16F10 cells.
Transcriptions of TRP1 were significantly attenuated in a
dose-dependent manner (Fig. 12a). Expressions of TRP1
were significantly decreased by Nos. 6 and 7 (Fig. 12b).
Aerial part of P. thunbergiana inhibits MITF
expression through the activation of Akt/GSK-3b
signaling pathway
We found that the aerial Part of P. thunbergiana inhibits
transcription of tyrosinase and TRP1 through MITF down-
regulation. As shown in Fig. 13, expression of MITF was
decreased by treatments with Nos. 6 and 7. We assessed
phosphorylation of GSK-3b and ERK by implementing
western blot since activated Akt/GSK-3b and MEK/ERK
Fig. 8 Comparison of cell-free
tyrosinase activity of aerial part
of P. thunbergiana. Reactions
were performed in potassium
phosphate buffer with L-DOPA
and mushroom tyrosinase. After
2 min, tyrosinase activity was
assessed by measuring the
absorbance at 475 nm and
expressed relative to the
controls. Kojic acid was used as
a positive control
Fig. 9 Inhibitory effects of aerial part of P. thunbergiana on cellular
tyrosinase activity. B16F10 cells were pre-cultured with a-MSH for
24 h, and incubated for 48 h more in a medium containing several
concentrations (10, 50, and 100 lg/mL) of extract No. 6 (a) or No. 7
(b). The cellular tyrosinase activity was measured and the results are
expressed relative to controls. *p \ 0.05, **p \ 0.01, and
***p \ 0.001 compared to a-MSH-stimulated cells
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signals degrade MITF. Phosphorylation of GSK-3b was
significantly enhanced by Nos. 6 and 7, respectively.
p-ERK was not significantly influenced.
Therefore, we examined melanin formations in B16F10
cells co-treated with No. 6 or 7 and LY294002 as Akt/
GSK-3b-specific inhibitor. As shown in Fig. 14, treatment
of LY294002 induced, and treatment of Nos. 6 and 7
inhibited melanin synthesis compared with control. The
melanin production, suppressed by Nos. 6 and 7, was
restored by LY294002. These results suggested that the
aerial part of P. thunbergiana activates Akt/GSK-3b.
Evaluation of the in vivo depigmenting activity
of aerial part of P. thunbergiana
To survey the potentiality as human whitening agent, the de-
pigmenting activity of aerial part of P. thunbergiana was
estimated by in vivo system using melanin-procession hairless
Fig. 10 Effects of aerial part of P. thunbergiana on mRNA and
proteins expression of tyrosinase. B16F10 cells were treated with a-
MSH and No. 6 or No. 7 for the indicated concentration. mRNA
levels (a) and expression levels (b) of tyrosinase were estimated.
GAPDH was used as an internal standard. c–f Quantitation of the
western blots by using GAPDH as the loading control. *p \ 0.05,
**p \ 0.01, and ***p \ 0.001 compared to a-MSH-stimulated cells.
###p \ 0.001 compared to nonstimulated cells
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mice for 19 days. As shown in Fig. 15, the degrees of pig-
mentation were measured as L* value representing the
lightness of the color. The values of UVB-exposed control
group (UVB) have significantly decreased compared with
control group (CON) since 6 day. The treatments with No. 6
creams mitigated pigmentation, respectively. The L* val-
ues were significantly higher than UVB-exposed control
group (UVB) in No. 6 1 % cream-applied animals [No. 6
(1 %)] after 9 day. Besides, in No. 6 3 % cream-applied
animals [No. 6 (3 %)], the values were not decreased by
UVB irradiation and have been significantly higher than the
values of UVB-exposed control (UVB) since 8 day. Fur-
thermore, the values have increased at comparing with
control group (CON) since 14 day (Fig. 15a). For positive
control, the calculated UVB-induced decreases of L* val-
ues were alleviated by application of kojic acid 1 % cream
(Kojic acid) (Fig. 15b).
Microscopic observation of the epidermis
Effects of aerial part of P. thunbergiana on pigmentation in
UVB-irradiated mice were confirmed by Fontana–Masson
staining (Fig. 15c). In the UVB-exposed-control epidermis,
an induction of melanogenesis was observed compared to
controls. In mice applied with No. 6 (1 and 3 %), mela-
nogenesis was reduced.
Discussion
Currently, numerous compounds are used for skin whit-
ening, such as arbutin, hydroquinone, and kojic acid.
However, there is growing interest in finding alternative
agents since the existing ones possess mutagenic prop-
erties and can induce skin disorders or low depigmenting
activity [8, 20].We investigated, therefore, the effects of
the aerial part of P. thunbergiana, an overlooked
resource, on melanin synthesis. Both aqueous and EtOAc
fractions of the extracts obtained using a range of EtOH
densities (0, 30, 70, and 95 %) were studied.
We found that the EtOAc fraction significantly reduced
melanin synthesis in the B16F10 melanin-processing cell
lines (Fig. 5) without causing cytotoxicity (Fig. 4). The P.
thunbergiana extracts exhibited dose-dependent inhibition,
with extract Nos. 6 and 7 (30 and 70 % ethanol, respec-
tively) proving to be excellent melanogenesis inhibitors
(Fig. 6). In addition, anti-pigmentation effects of the aerial
part of P. thunbergiana were clearly demonstrated by the
intracellular melanin accumulation observed using staining
techniques (Fig. 7).
A number of mechanisms exist for the regulation of
melanogenesis [10]. The most common target for depig-
menting agents is tyrosinase, the rate-limiting enzyme of
melanogenesis. Whitening ingredients such as ascorbic
acid, thio-containing compounds, phenolic compounds,
and kojic acid inhibit tyrosinase enzyme activity [6]. In this
study, we have established that the aerial part of P. thun-
bergiana reduces tyrosinase activity through its effect on
cellular tyrosinase in a-MSH-treated B16F10 cells (Fig. 9).
However, the aerial part of P. thunbergiana had no direct
inhibitory effects on tyrosinase (Fig. 8). These results
indicate that the anti-melanogenesis activity of the aerial
part of P. thunbergiana is involved in superior levels reg-
ulating tyrosinase enzyme such as transcription, transla-
tion, and maturation [23].
To understand the mechanisms of inhibitory effects on
melanogenesis, we examined the effects on mRNA and
protein expression of tyrosinase and TRP1, enzymes
involved in melanogenesis. Aerial part of P. thunbergiana
inhibits transcription and protein levels of tyrosinase and
TRP1 (Figs. 10, 12).
Transcription of tyrosinase and TRP1 is promoted by
MITF [2, 32]. We found out that MITF was down-reg-
ulated by aerial part of P. thunbergiana (Fig. 13). It was
reported that the activation of Akt/GSK-3b and MEK/
ERK signaling pathway downgrades activity and stability
of MITF and leads to degradation [13]. Accordingly, we
investigated the phosphorylation of GSK-3b and ERK.
Phosphorylation of GSK-3b was increased significantly
by aerial part of P. thunbergiana in a dose-dependent
manner. p-ERK had no change (Fig. 13). In addition, we
found that melanin formations, which were inhibited by
aerial part of P. thunbergiana, recovered with the Akt/
GSK-3b-specific inhibitor LY294002 (Fig. 14). These
results mean that aerial part of P. thunbergiana inhibits
Fig. 11 Inhibitory effects on a-glucosidase activity. a-Glucosidase
was incubated with acarbose, Nos. 6, 7 (500 lg/mL) and PNPG. Each
percentage value of a-glucosidase activity is reported relative to
control. *p \ 0.05, **p \ 0.01, and ***p \ 0.001 compared to
control
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MITF through modulation of the Akt/GSK-3b pathway,
not MEK/ERK.
Tyrosinase, the key enzyme of melanogenesis, is one of
the glycoprotein which completes its maturation by pro-
cessing N-glycosylation. Initial tyrosinase is glycosylated
when translated polypeptide chain translocates into the
endoplasmic reticulum (ER). After trimming by a-gluco-
sidase, glycosylated tyrosinase interacts with chaperones
and folds. Folded tyrosinase is completely matured via
acquisition of two Cu2? in Golgi and transported to mel-
anosome [4]. Our data revealed that aerial part of P.
thunbergiana reduces tyrosinase maturation (Fig. 10) by
inhibiting a-glucosidase (Fig. 11).
UV radiation is a strong inducer of oxidative stress,
contributing to skin pigmentation. Therefore, antioxidants
can reduce melanogenesis [3, 19]. In this study, we
detected antioxidant activity in the extracts of the aerial
part of P. thunbergiana using DPPH assay, with the EtOAc
fractions exhibiting stronger antioxidant properties than the
aqueous fractions (data not shown). The EtOAc-soluble
fractions showed remarkable scavenging effects compared
to those of ascorbic acid, a well-known antioxidant [22].
The antioxidant activity could be regarded as one of the
reasons that the aerial part of P. thunbergiana has anti-
melanogenesis activity. Further study about antioxidant
effect will be needed, because there are many mechanism
linking antioxidant activity and melanin synthesis [27, 29].
Taken together, the molecular and biological mecha-
nisms underlying the inhibition of melanogenesis are
mediated via complex pathways (Fig. 16). We confirmed
that there are a lot of isoflavones in aerial part of P.
thunbergiana (Table 1). The isoflavones are potent anti-
oxidant agents and major active compounds of several
Fig. 12 Effects of aerial part of P. thunbergiana on mRNA and
proteins expression of TRP1. B16F10 cells were treated with a-MSH
and No. 6 or No. 7 for the indicated concentration. mRNA levels
(a) and expression levels (b) of TRP1 were estimated. GAPDH was
used as an internal standard. c–d Quantitation of the western blots by
using GAPDH as the loading control. *p \ 0.05 and ***p \ 0.001
compared to a-MSH-stimulated cells. ###p \ 0.001 compared to
nonstimulated cells
cFig. 13 Effects of aerial part of P. thunbergiana on expression of
melanogenesis-related proteins. B16F10 cells were treated with a-
MSH and No. 6 or No. 7 for the indicated concentration. Western blot
assay were performed to estimate and expression levels of total MITF,
p-ERK and p-GSK-3b. Protein loading amounts were confirmed by
GAPDH expression. b–g Quantitation of the western blots by
using GAPDH as the loading control. *p \ 0.05, **p \ 0.01, and
***p \ 0.001 compared to a-MSH-stimulated cells
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Fig. 14 Effects of aerial part of P. thunbergiana on regulation of
Akt/GSK-3b signal. Melanin contents were evaluated. Cells were
pretreated in the absence (-) or presence (?) of LY294002 (20 lM)
for 1 h and then cultured without (-) or with (?) 50 lg/mL of No. 6
(a) and 7 (b) for 48 h. ***p \ 0.001 compared to sample-treated only
Fig. 15 Effects of aerial part of P. thunbergiana on pigmentation in
UV-irradiated animal. a Melanin possessing hairless mice were
treated with 100 mg of cream base, kojic acid 1 % cream, No. 6 1 and
3 % cream on dorsal skins every day. UVB irradiation was performed
according to the indicated schedules. The lightness (L* value) of skin
was measured before applying cream on each day. b DL* values of
each animal were calculated; values of days 17, 18, 19 minus values
of days 2, 3, 4. Data represent mean ± SEM (n = 3). #p \ 0.05,
##p \ 0.01, and ###p \ 0.001 compared with CON. *p \ 0.05,
**p \ 0.01, and ***p \ 0.001 compared with UVB group. c Micro-
scopic images of skin sections. Melanogenesis of dorsal skin was
highlighted by Fontana–Masson staining. Arrows indicate
pigmentation
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Leguminosae plants (Fig. 3) [7, 21]. In practice, a study
about the effect of genistein on melanogenesis by inhibi-
tory effect on a-glucosidase has been reported [37]. Thus,
it could be anticipated that the isoflavones are major
components of aerial part of P. thunbergiana for anti-
melanogenic effect. To define active compound, additional
studies such as column chromatography and nuclear mag-
netic resonance (NMR) are going to be progressed.
Furthermore, we demonstrated that topical spread of
cream contained extract of aerial part of P. thunbergiana
can inhibit pigmentation in vivo study (Fig. 15). Applica-
tion of aerial part of P. thunbergiana reduced UVB-
induced-pigmentation, and the effect was more dramatical
than kojic acid. In case of treatment of aerial part of P.
thunbergiana 3 % contained cream, the skin lightness was
higher than control that was not exposed to UVB. Fur-
thermore, by Fontana–Masson staining study, it was iden-
tified that melanin distribution of epidermis induced by
UVB was inhibited by aerial part of P. thunbergiana
(Fig. 15c). These results of our study suggest that aerial
part of P. thunbergiana can be used as a skin-whitening
agent.
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